These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2980309)

  • 21. Iopentol in urography. A clinical comparison between iopentol and metrizoate including delayed reactions.
    Sortland O; Johansen JG; Oksendal AN; Waaler A
    Acta Radiol; 1992 Jul; 33(4):368-73. PubMed ID: 1633050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of iopentol in the rat.
    Michelet AA; Skinnemoen K
    Acta Radiol Suppl; 1987; 370():101-4. PubMed ID: 2980301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New x-ray contrast agents. The chemical, biological, and physical properties of 5-heterocycle substituted 2,4,6-triiodo-1,3-benzenedicarboxamide derivatives.
    Ranganathan RS; Arunachalam T; Diamantidis G; Duncan L; Emswiler J; Marinelli E; Neubeck R; Pillai R; Wedeking P; Tweedle MF
    Invest Radiol; 1991 Nov; 26 Suppl 1():S156-8; discussion S165-6. PubMed ID: 1808114
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative evaluation of 2 non-ionic contrast media, iopentol (350 mgI/ml) and iopamidol (370 mgI/ml) in coronary angiography].
    Maddestra N; Di Cesare A; Salute L; Toppetti A; Minguzzi P; Marelli C; Bonomo L
    Radiol Med; 1994 Oct; 88(4):396-400. PubMed ID: 7997610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of iopentol and other non-ionic contrast agents in biologic fluids by high-performance liquid chromatography.
    Skinnemoen K; Fagervoll R; Jacobsen T
    Acta Radiol Suppl; 1987; 370():23-5. PubMed ID: 2980306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sodium addition to non-ionic contrast media on cardiac contractile force. Perfusion of the isolated rabbit heart with iohexol and iopentol containing 0 to 154 mmol Na+/l added as NaCl.
    Bååth L; Almén T; Oksendal A
    Acta Radiol; 1990 Jan; 31(1):99-104. PubMed ID: 2340228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of large molecular aggregates in X-ray contrast media.
    Skotland T; Sontum PC; Christiansen C
    Eur Radiol; 2007 May; 17(5):1377-9. PubMed ID: 16951928
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduction of the risk of ventricular fibrillation in the isolated rabbit heart by small additions of electrolytes to non-ionic monomeric contrast media.
    Bååth L; Almén T
    Acta Radiol; 1989; 30(3):327-33. PubMed ID: 2736187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereoisomerism in contrast media. Ioversol.
    Dunn J; Lin Y; Miller D; Rogic M; Neumann W; Woulfe S; White D
    Invest Radiol; 1990 Sep; 25 Suppl 1():S102-3. PubMed ID: 2283217
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolism and excretion of iopentol in the pig.
    Leunbach I; Skinnemoen K; Golman K
    Acta Radiol Suppl; 1987; 370():105-7. PubMed ID: 2980302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of the X-ray contrast agent iodixanol=3,3',5,5'-tetrakis(2,3-dihydroxypropylcarbamoyl)- 2,2',4,4',6, 6'-hexaiodo-N,N'-(2-hydroxypropane-1,3-diyl)-diacetanili de towards acid, base, oxygen, heat and light.
    Priebe H; Aukrust A; Bjørsvik HR; Tønseth CP; Wiggen UN
    J Clin Pharm Ther; 1999 Jun; 24(3):227-35. PubMed ID: 10438183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The new nonionic contrast preparation for myelography iotrolan].
    Sviridov NK
    Zh Vopr Neirokhir Im N N Burdenko; 1994; (2):35-6. PubMed ID: 8209595
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial.
    Jakobsen JA; Hagve TA; Holager T; Waaler A; Haider T; Andrew E; Aakhus T
    Eur J Radiol; 1989 Nov; 9(4):203-7. PubMed ID: 2591384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New iodinated, low-osmolar contrast media. A revised concept of hydrophilicity.
    Bonnemain B; Meyer D; Schaefer M; Dugast-Zrihen M; Legreneur S; Doucet D
    Invest Radiol; 1990 Sep; 25 Suppl 1():S104-6. PubMed ID: 2283218
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal effects of the non-ionic contrast medium iopentol after intravenous injection in healthy volunteers.
    Jakobsen JA; Berg KJ; Waaler A; Andrew E
    Acta Radiol; 1990 Jan; 31(1):87-91. PubMed ID: 2187515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of a radiographic contrast media (Iopentol) with different viscosities on capillary perfusion in patients with coronary artery disease.
    Jung F; Mrowietz C; Gerk U; Franke RP
    Clin Hemorheol Microcirc; 2013; 53(1-2):201-8. PubMed ID: 22596231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo interference of Ioversol in serum and urine capillary electrophoresis: an optimized protocol for sample collection.
    Quirós C; Cillero AI; Bretaña L; García M; Prieto B; Álvarez FV
    Clin Chem Lab Med; 2018 Jan; 56(2):e53-e55. PubMed ID: 28771431
    [No Abstract]   [Full Text] [Related]  

  • 38. Contrast media: future aspects.
    Weinmann HJ; Platzek J; Schirmer H; Pietsch H; Carretero J; Harto J; Medina J; Riefke B; Martín J
    Eur Radiol; 2005 Nov; 15 Suppl 4():D70-3. PubMed ID: 16479651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Balanced facial hydrophilicity of ioversol: a qualitative approach of hydrophilicity].
    Meyer D; Bonnemain B; Dugast-Zrihen M; Le Greneur S
    Ann Radiol (Paris); 1992; 35(4 Pt 2):263-6. PubMed ID: 1296488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation and stability of iopentol.
    Skinnemoen K; Fagervoll R; Aanstad L; Jacobsen T
    Acta Radiol Suppl; 1987; 370():37-40. PubMed ID: 2980309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.